1. Home
  2. JOE vs MLYS Comparison

JOE vs MLYS Comparison

Compare JOE & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo St. Joe Company (The)

JOE

St. Joe Company (The)

HOLD

Current Price

$58.87

Market Cap

3.4B

Sector

Real Estate

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$37.20

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOE
MLYS
Founded
1936
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
JOE
MLYS
Price
$58.87
$37.20
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$47.33
AVG Volume (30 Days)
233.5K
1.5M
Earning Date
10-29-2025
02-11-2026
Dividend Yield
1.09%
N/A
EPS Growth
53.79
N/A
EPS
1.80
N/A
Revenue
$488,689,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.69
N/A
Revenue Growth
26.89
N/A
52 Week Low
$40.19
$8.24
52 Week High
$63.13
$47.65

Technical Indicators

Market Signals
Indicator
JOE
MLYS
Relative Strength Index (RSI) 45.51 43.16
Support Level $60.78 $36.50
Resistance Level $63.13 $38.23
Average True Range (ATR) 1.37 1.68
MACD -0.55 0.09
Stochastic Oscillator 15.04 41.96

Price Performance

Historical Comparison
JOE
MLYS

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: